Global Microbial Fermentation APIs Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Microbial Fermentation APIs Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).

According to APO Research, The global Microbial Fermentation APIs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Microbial Fermentation APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Microbial Fermentation APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Microbial Fermentation APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Microbial Fermentation APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Microbial Fermentation APIs include Merck, Ajinomoto, HGPF, Huaxing, North China Pharmaceutical, Topfond, DSM, Tianyao and CSPC Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Microbial Fermentation APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Microbial Fermentation APIs, also provides the sales of main regions and countries. Of the upcoming market potential for Microbial Fermentation APIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microbial Fermentation APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Microbial Fermentation APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Microbial Fermentation APIs sales, projected growth trends, production technology, application and end-user industry.

Microbial Fermentation APIs segment by Company

Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Microbial Fermentation APIs segment by Type

Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
Microbial Fermentation APIs segment by Application

Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Microbial Fermentation APIs segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Fermentation APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbial Fermentation APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Fermentation APIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microbial Fermentation APIs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbial Fermentation APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microbial Fermentation APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Microbial Fermentation APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Microbial Fermentation APIs Market Size, 2019 VS 2023 VS 2030
1.3 Global Microbial Fermentation APIs Market Size Estimates and Forecasts (2019-2030)
1.4 Global Microbial Fermentation APIs Sales Estimates and Forecasts (2019-2030)
1.5 Global Microbial Fermentation APIs Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Microbial Fermentation APIs Market Dynamics
2.1 Microbial Fermentation APIs Industry Trends
2.2 Microbial Fermentation APIs Industry Drivers
2.3 Microbial Fermentation APIs Industry Opportunities and Challenges
2.4 Microbial Fermentation APIs Industry Restraints
3 Microbial Fermentation APIs Market by Manufacturers
3.1 Global Microbial Fermentation APIs Revenue by Manufacturers (2019-2024)
3.2 Global Microbial Fermentation APIs Sales by Manufacturers (2019-2024)
3.3 Global Microbial Fermentation APIs Average Sales Price by Manufacturers (2019-2024)
3.4 Global Microbial Fermentation APIs Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Microbial Fermentation APIs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Microbial Fermentation APIs Manufacturers, Product Type & Application
3.7 Global Microbial Fermentation APIs Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Microbial Fermentation APIs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Microbial Fermentation APIs Players Market Share by Revenue in 2023
3.8.3 2023 Microbial Fermentation APIs Tier 1, Tier 2, and Tier 3
4 Microbial Fermentation APIs Market by Type
4.1 Microbial Fermentation APIs Type Introduction
4.1.1 Antibiotics
4.1.2 Amino Acids
4.1.3 Vitamin
4.1.4 Nucleotide
4.1.5 Organic Acid
4.1.6 Alcohol
4.1.7 Biological Products
4.1.8 Hormone
4.2 Global Microbial Fermentation APIs Sales by Type
4.2.1 Global Microbial Fermentation APIs Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Microbial Fermentation APIs Sales by Type (2019-2030)
4.2.3 Global Microbial Fermentation APIs Sales Market Share by Type (2019-2030)
4.3 Global Microbial Fermentation APIs Revenue by Type
4.3.1 Global Microbial Fermentation APIs Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Microbial Fermentation APIs Revenue by Type (2019-2030)
4.3.3 Global Microbial Fermentation APIs Revenue Market Share by Type (2019-2030)
5 Microbial Fermentation APIs Market by Application
5.1 Microbial Fermentation APIs Application Introduction
5.1.1 Hospitals
5.1.2 Research & Academic Laboratories
5.1.3 Pharmaceutical & Biotechnology Companies
5.2 Global Microbial Fermentation APIs Sales by Application
5.2.1 Global Microbial Fermentation APIs Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Microbial Fermentation APIs Sales by Application (2019-2030)
5.2.3 Global Microbial Fermentation APIs Sales Market Share by Application (2019-2030)
5.3 Global Microbial Fermentation APIs Revenue by Application
5.3.1 Global Microbial Fermentation APIs Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Microbial Fermentation APIs Revenue by Application (2019-2030)
5.3.3 Global Microbial Fermentation APIs Revenue Market Share by Application (2019-2030)
6 Global Microbial Fermentation APIs Sales by Region
6.1 Global Microbial Fermentation APIs Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Microbial Fermentation APIs Sales by Region (2019-2030)
6.2.1 Global Microbial Fermentation APIs Sales by Region (2019-2024)
6.2.2 Global Microbial Fermentation APIs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Microbial Fermentation APIs Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Microbial Fermentation APIs Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Microbial Fermentation APIs Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Microbial Fermentation APIs Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Microbial Fermentation APIs Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Microbial Fermentation APIs Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Microbial Fermentation APIs Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Microbial Fermentation APIs Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Microbial Fermentation APIs Revenue by Region
7.1 Global Microbial Fermentation APIs Revenue by Region
7.1.1 Global Microbial Fermentation APIs Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Microbial Fermentation APIs Revenue by Region (2019-2024)
7.1.3 Global Microbial Fermentation APIs Revenue by Region (2025-2030)
7.1.4 Global Microbial Fermentation APIs Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Microbial Fermentation APIs Revenue (2019-2030)
7.2.2 North America Microbial Fermentation APIs Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Microbial Fermentation APIs Revenue (2019-2030)
7.3.2 Europe Microbial Fermentation APIs Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Microbial Fermentation APIs Revenue (2019-2030)
7.4.2 Asia-Pacific Microbial Fermentation APIs Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Microbial Fermentation APIs Revenue (2019-2030)
7.5.2 LAMEA Microbial Fermentation APIs Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Microbial Fermentation APIs Product Portfolio
8.1.5 Merck Recent Developments
8.2 Ajinomoto
8.2.1 Ajinomoto Comapny Information
8.2.2 Ajinomoto Business Overview
8.2.3 Ajinomoto Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Ajinomoto Microbial Fermentation APIs Product Portfolio
8.2.5 Ajinomoto Recent Developments
8.3 HGPF
8.3.1 HGPF Comapny Information
8.3.2 HGPF Business Overview
8.3.3 HGPF Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 HGPF Microbial Fermentation APIs Product Portfolio
8.3.5 HGPF Recent Developments
8.4 Huaxing
8.4.1 Huaxing Comapny Information
8.4.2 Huaxing Business Overview
8.4.3 Huaxing Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Huaxing Microbial Fermentation APIs Product Portfolio
8.4.5 Huaxing Recent Developments
8.5 North China Pharmaceutical
8.5.1 North China Pharmaceutical Comapny Information
8.5.2 North China Pharmaceutical Business Overview
8.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 North China Pharmaceutical Microbial Fermentation APIs Product Portfolio
8.5.5 North China Pharmaceutical Recent Developments
8.6 Topfond
8.6.1 Topfond Comapny Information
8.6.2 Topfond Business Overview
8.6.3 Topfond Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Topfond Microbial Fermentation APIs Product Portfolio
8.6.5 Topfond Recent Developments
8.7 DSM
8.7.1 DSM Comapny Information
8.7.2 DSM Business Overview
8.7.3 DSM Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 DSM Microbial Fermentation APIs Product Portfolio
8.7.5 DSM Recent Developments
8.8 Tianyao
8.8.1 Tianyao Comapny Information
8.8.2 Tianyao Business Overview
8.8.3 Tianyao Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Tianyao Microbial Fermentation APIs Product Portfolio
8.8.5 Tianyao Recent Developments
8.9 CSPC Pharma
8.9.1 CSPC Pharma Comapny Information
8.9.2 CSPC Pharma Business Overview
8.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 CSPC Pharma Microbial Fermentation APIs Product Portfolio
8.9.5 CSPC Pharma Recent Developments
8.10 Northeast Pharm
8.10.1 Northeast Pharm Comapny Information
8.10.2 Northeast Pharm Business Overview
8.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Northeast Pharm Microbial Fermentation APIs Product Portfolio
8.10.5 Northeast Pharm Recent Developments
8.11 Lukang Pharmaceutical
8.11.1 Lukang Pharmaceutical Comapny Information
8.11.2 Lukang Pharmaceutical Business Overview
8.11.3 Lukang Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Lukang Pharmaceutical Microbial Fermentation APIs Product Portfolio
8.11.5 Lukang Pharmaceutical Recent Developments
8.12 Luwei Pharmaceutical
8.12.1 Luwei Pharmaceutical Comapny Information
8.12.2 Luwei Pharmaceutical Business Overview
8.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Luwei Pharmaceutical Microbial Fermentation APIs Product Portfolio
8.12.5 Luwei Pharmaceutical Recent Developments
8.13 Jiangshan (DSM)
8.13.1 Jiangshan (DSM) Comapny Information
8.13.2 Jiangshan (DSM) Business Overview
8.13.3 Jiangshan (DSM) Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Jiangshan (DSM) Microbial Fermentation APIs Product Portfolio
8.13.5 Jiangshan (DSM) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Microbial Fermentation APIs Value Chain Analysis
9.1.1 Microbial Fermentation APIs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Microbial Fermentation APIs Production Mode & Process
9.2 Microbial Fermentation APIs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Microbial Fermentation APIs Distributors
9.2.3 Microbial Fermentation APIs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings